Insigneo Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$804K Sell
12,813
-1,188
-8% -$95K 0.06% 256
2025
Q4
$1.33M Sell
14,001
-1,652
-11% -$162K 0.1% 175
2025
Q3
$1.53M Buy
15,653
+1,837
+13% +$190K 0.11% 152
2025
Q2
$1.48M Sell
13,816
-815
-6% -$82.5K 0.13% 142
2025
Q1
$1.48M Buy
14,631
+2,906
+25% +$293K 0.15% 128
2024
Q4
$1.05M Sell
11,725
-6,694
-36% -$589K 0.11% 159
2024
Q3
$1.54M Sell
18,419
-3,540
-16% -$279K 0.16% 131
2024
Q2
$1.6M Buy
21,959
+4,763
+28% +$349K 0.18% 118
2024
Q1
$1.18M Sell
17,196
-1,799
-9% -$116K 0.14% 141
2023
Q4
$1.1M Buy
18,995
+9,421
+98% +$503K 0.15% 135
2023
Q3
$506K Sell
9,574
-3,779
-28% -$198K 0.1% 183
2023
Q2
$722K Sell
13,353
-1,605
-11% -$83.8K 0.14% 150
2023
Q1
$746K Sell
14,958
-742
-5% -$35K 0.24% 81
2022
Q4
$726K Buy
+15,700
New +$680K 0.27% 77

Other funds holding BSX

Insigneo Advisory Services's BSX Position: Q1 2026 in Review

Insigneo Advisory Services reduced its Boston Scientific (BSX) stake by 8.5% in Q1 2026, selling an estimated $95K and leaving 12,813 shares worth $804K. The position accounts for 0.06% of the portfolio, ranked #256.

Insigneo Advisory Services first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.6M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Insigneo Advisory Services held 12,813 shares of Boston Scientific worth $804K as of Q1 2026.
  • Insigneo Advisory Services sold 1,188 Boston Scientific shares in Q1 2026, an estimated $95K.
  • Boston Scientific made up 0.06% of Insigneo Advisory Services's portfolio in Q1 2026, its #256 holding.
  • Insigneo Advisory Services first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
  • Insigneo Advisory Services's Boston Scientific position peaked at $1.6M in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.